RHHVF
Price
$320.40
Change
-$9.60 (-2.91%)
Updated
Jul 3 closing price
Capitalization
250.69B
18 days until earnings call
SNPHY
Price
$11.74
Change
+$0.20 (+1.73%)
Updated
Jul 3 closing price
Capitalization
3.26B
Interact to see
Advertisement

RHHVF vs SNPHY

Header iconRHHVF vs SNPHY Comparison
Open Charts RHHVF vs SNPHYBanner chart's image
Roche Holding
Price$320.40
Change-$9.60 (-2.91%)
Volume$25.21K
Capitalization250.69B
Santen Pharmaceutical
Price$11.74
Change+$0.20 (+1.73%)
Volume$760
Capitalization3.26B
RHHVF vs SNPHY Comparison Chart in %
Loading...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHVF vs. SNPHY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHVF is a Hold and SNPHY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (RHHVF: $320.40 vs. SNPHY: $11.74)
Brand notoriety: RHHVF and SNPHY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHVF: 187% vs. SNPHY: 17%
Market capitalization -- RHHVF: $250.69B vs. SNPHY: $3.26B
RHHVF [@Pharmaceuticals: Major] is valued at $250.69B. SNPHY’s [@Pharmaceuticals: Major] market capitalization is $3.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHVF’s FA Score shows that 2 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).

  • RHHVF’s FA Score: 2 green, 3 red.
  • SNPHY’s FA Score: 0 green, 5 red.
According to our system of comparison, RHHVF is a better buy in the long-term than SNPHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHVF’s TA Score shows that 5 TA indicator(s) are bullish while SNPHY’s TA Score has 4 bullish TA indicator(s).

  • RHHVF’s TA Score: 5 bullish, 3 bearish.
  • SNPHY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SNPHY is a better buy in the short-term than RHHVF.

Price Growth

RHHVF (@Pharmaceuticals: Major) experienced а -2.61% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +4.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

RHHVF is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHVF($251B) has a higher market cap than SNPHY($3.26B). RHHVF has higher P/E ratio than SNPHY: RHHVF (19.34) vs SNPHY (15.60). SNPHY YTD gains are higher at: 16.057 vs. RHHVF (14.429). RHHVF has higher annual earnings (EBITDA): 19.1B vs. SNPHY (17.2B). SNPHY has more cash in the bank: 62.3B vs. RHHVF (7.51B). RHHVF has less debt than SNPHY: RHHVF (25.4B) vs SNPHY (40.1B). SNPHY has higher revenues than RHHVF: SNPHY (270B) vs RHHVF (60B).
RHHVFSNPHYRHHVF / SNPHY
Capitalization251B3.26B7,690%
EBITDA19.1B17.2B111%
Gain YTD14.42916.05790%
P/E Ratio19.3415.60124%
Revenue60B270B22%
Total Cash7.51B62.3B12%
Total Debt25.4B40.1B63%
FUNDAMENTALS RATINGS
RHHVF vs SNPHY: Fundamental Ratings
RHHVF
SNPHY
OUTLOOK RATING
1..100
7856
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5246
P/E GROWTH RATING
1..100
1787
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (15) in the null industry is somewhat better than the same rating for SNPHY (66). This means that RHHVF’s stock grew somewhat faster than SNPHY’s over the last 12 months.

RHHVF's Profit vs Risk Rating (100) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

RHHVF's SMR Rating (99) in the null industry is in the same range as SNPHY (100). This means that RHHVF’s stock grew similarly to SNPHY’s over the last 12 months.

SNPHY's Price Growth Rating (46) in the null industry is in the same range as RHHVF (52). This means that SNPHY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHVF's P/E Growth Rating (17) in the null industry is significantly better than the same rating for SNPHY (87). This means that RHHVF’s stock grew significantly faster than SNPHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHVFSNPHY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
63%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 9 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
48%
Bullish Trend 3 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBSTF0.05N/A
+3.73%
THE CANNABIST COMPANY HOLDINGS INC.
NHMAF5.25N/A
N/A
Nihon M and A Center Inc
ONVC1.60N/A
N/A
Online Vacation Center Holdings Corp.
REMYF55.90N/A
N/A
Remy Cointreau SA
NMPRY3.80N/A
N/A
Navios Maritime Holdings, Inc.

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-2.91%
RHHBY - RHHVF
66%
Loosely correlated
-1.73%
RHHBF - RHHVF
29%
Poorly correlated
N/A
OTSKY - RHHVF
14%
Poorly correlated
-1.50%
SNPHY - RHHVF
7%
Poorly correlated
+1.80%
SNPHF - RHHVF
4%
Poorly correlated
N/A
More

SNPHY and

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+1.80%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
-2.91%
RHHBF - SNPHY
6%
Poorly correlated
N/A
RHHBY - SNPHY
5%
Poorly correlated
-1.73%
OTSKY - SNPHY
4%
Poorly correlated
-1.50%
More